Dr. Sprugel has worked in preclinical research and development in the biotechnology industry in Seattle for over 25 years, including work at ZymoGenetics, PathoGenesis and Chiron. She is currently a Scientific Director in Toxicology Sciences at Amgen in Seattle, where she works on safety assessments and nonclinical development strategies for drugs in the areas of inflammation and oncology.
Dr. Sprugel has worked in preclinical research and development in the biotechnology industry in Seattle for over 25 years, including work at ZymoGenetics, PathoGenesis and Chiron. She is currently a Scientific Director in Toxicology Sciences at Amgen in Seattle, where she works on safety assessments and nonclinical development strategies for drugs in the areas of inflammation and oncology.
Protein pharmacology: identification and testing of therapeutic potential of novel proteins Biotherapeutic drug development, especially the evolving regulatory environment for biologics Inhalation toxicology
Not available to mentor new students in autumn 2020.
Research Interests:
Protein pharmacology: identification and testing of therapeutic potential of novel proteins Biotherapeutic drug development, especially the evolving regulatory environment for biologics Inhalation toxicology
Regulatory toxicology- small molecules and biologics
Communicating about science with the public
K-12 science education and outreach
